Lv3
380 积分 2024-12-14 加入
Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids
2个月前
已完结
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non−Small Cell Lung Cancer
2个月前
已完结
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non–Small-Cell Lung Cancer
2个月前
已完结
Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors
2个月前
已关闭
Proton pump inhibitors reduce nivolumab efficacy in unresectable advanced or recurrent gastric cancer
2个月前
已完结
Impact of Proton Pump Inhibitor Use on the Efficacy of IO–IO Versus IO–TKI Therapy in Metastatic Renal Cell Carcinoma
2个月前
已完结
Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
2个月前
已完结
Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma
2个月前
已完结
Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
2个月前
已完结
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
2个月前
已完结
皖公网安备34019202002308
